Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Robert F. Kennedy Jr.
Biotech
FDA delays force Daré to shelve phase 3 plans: WSJ
In the last two months, the FDA has pushed back the date it would provide guidance twice, according to Daré's CEO.
Gabrielle Masson
Apr 17, 2025 3:03pm
Biotech CEOs say they already feel impact of FDA restructure
Apr 10, 2025 1:56pm
16 states sue Trump administration over NIH grant cancellations
Apr 4, 2025 2:53pm
Researchers, public health group sue over $1.1B in revoked funds
Apr 2, 2025 3:00pm
Leader of National Human Genome Research Institute put on leave
Apr 1, 2025 10:13am
Trump admin slashes 4,700 FDA and NIH jobs
Mar 27, 2025 10:40am
